Nifty

:

22147.00

Sensex

:

73088.33

151.15 (0.69%)
599.34 (0.83%)

Login

Nifty
Sensex

:
:

22147.00
73088.33

151.15 (0.69%)
599.34 (0.83%)

Auro Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

65/99

BSE: 530233 | NSE: Not Listed

Watchlist

NSE BSE

187.55

18-Apr-2024

Open
High
Low
Previous Close

189.90
192.50
181.05
182.75

Volume
Traded Value (lacs)
52 Week High
52 Week Low

147
16.77
197.40
63.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

116.89
16.25
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

125.26
N/A
2.94

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

4.60
2.47
-0.84

EBITDA CAGR (%)

10 Years
5 Years
3 Years

4.71
-8.88
-17.14

PAT CAGR (%)

10 Years
5 Years
3 Years

15.45
-11.12
-30.22

P:E (Median)

8 Years
5 Years
3 Years

13.30
12.51
17.09

P:BV (Average)

8 Years
5 Years
3 Years

1.93
1.93
2.02

EV:EBITDA (Average)

8 Years
5 Years
3 Years

8.08
7.40
9.09

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 17.98 15.62 15.11% 13.41 12.56 6.77% 10.18 11.18 -8.94% 13.53 17.88 -24.33%
Expenses 13.90 15.18 -8.43% 10.38 11.54 -10.05% 9.03 10.61 -14.89% 11.17 16.98 -34.22%
EBITDA 4.08 0.45 806.67% 3.03 1.02 197.06% 1.15 0.58 98.28% 2.35 0.90 161.11%
EBIDTM 22.69% 2.87% 22.58% 8.11% 11.33% 5.15% 17.39% 5.04%
Other Income 0.42 0.43 -2.33% 0.32 -0.16 - 0.36 0.05 620.00% 0.62 0.28 121.43%
Interest 0.45 0.10 350.00% 0.35 0.32 9.38% 0.27 0.26 3.85% 0.13 0.40 -67.50%
Depreciation 0.27 0.27 0.00% 0.27 0.25 8.00% 0.27 0.25 8.00% 0.30 0.24 25.00%
PBT 3.79 0.51 643.14% 2.73 0.29 841.38% 0.98 0.12 716.67% 2.53 0.55 360.00%
Tax 1.05 0.14 650.00% 0.76 0.08 850.00% 0.27 0.03 800.00% 0.75 0.10 650.00%
PAT 2.73 0.37 637.84% 1.97 0.21 838.10% 0.71 0.08 787.50% 1.78 0.46 286.96%
PATM 15.21% 2.34% 14.68% 1.68% 6.95% 0.74% 13.18% 2.55%
EPS 4.41 0.59 647.46% 3.18 0.34 835.29% 1.14 0.13 776.92% 2.88 0.74 289.19%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 55.10 52.89 50.87 54.25 43.79 46.82 40.79 35.47 27.91 32.65 33.74 Net Sales Growth -3.74% 3.97% -6.23% 23.89% -6.47% 14.78% 15.00% 27.09% -14.52% -3.23% Cost Of Goods Sold 29.71 35.69 32.78 28.55 24.48 28.62 24.72 22.42 18.14 22.83 24.75 Gross Profit 25.39 17.20 18.08 25.70 19.31 18.20 16.07 13.06 9.77 9.82 9.00 GP Margin 46.09% 32.52% 35.54% 47.37% 44.10% 38.87% 39.40% 36.82% 35.01% 30.08% 26.67% Total Expenditure 44.48 48.50 46.24 43.01 37.52 39.83 34.44 31.05 25.11 29.71 30.97 Power & Fuel Cost - 2.08 1.67 1.60 1.69 1.64 1.48 1.29 1.02 1.40 1.31 % Of Sales - 3.93% 3.28% 2.95% 3.86% 3.50% 3.63% 3.64% 3.65% 4.29% 3.88% Employee Cost - 3.76 3.69 3.63 3.47 2.87 2.79 2.71 2.37 2.17 2.01 % Of Sales - 7.11% 7.25% 6.69% 7.92% 6.13% 6.84% 7.64% 8.49% 6.65% 5.96% Manufacturing Exp. - 1.47 1.65 2.09 1.72 1.32 1.25 1.24 1.02 1.07 0.95 % Of Sales - 2.78% 3.24% 3.85% 3.93% 2.82% 3.06% 3.50% 3.65% 3.28% 2.82% General & Admin Exp. - 2.46 3.46 3.39 3.44 2.48 1.96 1.28 0.78 0.52 0.42 % Of Sales - 4.65% 6.80% 6.25% 7.86% 5.30% 4.81% 3.61% 2.79% 1.59% 1.24% Selling & Distn. Exp. - 2.23 2.51 2.45 1.48 1.75 1.29 1.16 1.25 1.50 1.05 % Of Sales - 4.22% 4.93% 4.52% 3.38% 3.74% 3.16% 3.27% 4.48% 4.59% 3.11% Miscellaneous Exp. - 0.82 0.48 1.29 1.23 1.16 0.96 0.94 0.53 0.22 1.05 % Of Sales - 1.55% 0.94% 2.38% 2.81% 2.48% 2.35% 2.65% 1.90% 0.67% 1.42% EBITDA 10.61 4.39 4.63 11.24 6.27 6.99 6.35 4.42 2.80 2.94 2.77 EBITDA Margin 19.26% 8.30% 9.10% 20.72% 14.32% 14.93% 15.57% 12.46% 10.03% 9.00% 8.21% Other Income 1.72 0.94 1.09 0.76 0.97 0.96 0.51 0.53 0.42 0.24 0.06 Interest 1.20 0.81 0.83 0.46 0.58 0.87 1.21 1.18 1.66 1.66 1.53 Depreciation 1.11 1.07 1.02 1.04 1.02 1.01 0.93 0.86 0.68 0.72 0.74 PBT 10.03 3.45 3.87 10.51 5.64 6.07 4.73 2.92 0.88 0.80 0.58 Tax 2.83 1.00 1.03 3.33 1.59 1.67 1.20 2.11 0.00 0.00 0.00 Tax Rate 28.22% 28.99% 26.61% 31.68% 28.19% 27.51% 25.37% 72.26% 0.00% 0.00% 0.00% PAT 7.19 2.44 2.84 7.18 4.05 4.40 3.53 0.82 0.88 0.80 0.58 PAT before Minority Interest 7.19 2.44 2.84 7.18 4.05 4.40 3.53 0.82 0.88 0.80 0.58 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.05% 4.61% 5.58% 13.24% 9.25% 9.40% 8.65% 2.31% 3.15% 2.45% 1.72% PAT Growth 541.96% -14.08% -60.45% 77.28% -7.95% 24.65% 330.49% -6.82% 10.00% 37.93% EPS 11.60 3.94 4.58 11.58 6.53 7.10 5.69 1.32 1.42 1.29 0.94

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 34.20 31.52 28.58 21.50 17.41 12.98 9.41 8.59 7.70 6.90 Share Capital 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 Total Reserves 27.97 25.29 22.35 15.27 11.18 6.75 3.18 2.35 1.47 0.67 Non-Current Liabilities 3.66 3.31 4.07 4.72 6.06 7.89 11.40 7.23 7.52 7.40 Secured Loans 1.76 0.85 1.27 1.81 2.62 3.43 4.95 0.00 0.00 0.00 Unsecured Loans 0.26 0.81 1.12 1.35 1.95 3.02 4.93 7.23 7.52 7.40 Long Term Provisions 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 18.13 20.13 9.24 6.14 9.99 9.54 5.99 9.88 13.56 12.54 Trade Payables 11.48 4.86 5.75 4.74 5.18 5.30 4.93 3.58 3.51 4.27 Other Current Liabilities 0.73 1.37 1.17 0.79 0.83 1.48 1.06 0.90 1.16 1.34 Short Term Borrowings 4.26 11.79 0.66 0.00 3.53 2.75 0.00 5.39 8.89 6.93 Short Term Provisions 1.66 2.11 1.65 0.61 0.45 0.00 0.00 0.00 0.00 0.00 Total Liabilities 55.99 54.96 41.89 32.36 33.46 30.41 26.80 25.70 28.78 26.84 Net Block 12.62 13.61 13.56 14.24 14.59 13.02 13.00 9.13 9.80 10.51 Gross Block 25.47 25.39 24.32 23.96 23.29 20.72 19.76 15.50 15.49 15.47 Accumulated Depreciation 12.85 11.78 10.76 9.73 8.70 7.69 6.76 6.37 5.68 4.97 Non Current Assets 20.62 17.61 13.94 14.40 14.75 14.74 13.28 13.25 11.28 11.11 Capital Work in Progress 7.67 3.67 0.13 0.12 0.12 1.07 0.23 3.33 0.82 0.06 Non Current Investment 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 Long Term Loans & Adv. 0.29 0.28 0.20 0.00 0.00 0.59 0.00 0.74 0.61 0.49 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 35.38 37.35 27.96 17.95 18.71 15.67 13.53 12.45 17.50 15.73 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 11.76 4.25 2.55 4.06 3.37 1.49 1.33 4.31 5.59 7.82 Sundry Debtors 12.40 13.61 7.30 5.78 8.50 8.37 7.69 5.05 8.48 4.34 Cash & Bank 2.42 12.40 14.54 5.68 4.11 2.25 1.01 0.53 0.44 1.42 Other Current Assets 8.80 4.87 3.50 1.94 2.73 3.56 3.51 2.55 2.99 2.16 Short Term Loans & Adv. 2.86 2.22 0.08 0.48 0.28 0.27 1.10 0.26 0.92 0.47 Net Current Assets 17.24 17.22 18.72 11.81 8.72 6.13 7.54 2.57 3.94 3.19 Total Assets 56.00 54.96 41.90 32.35 33.46 30.41 26.81 25.70 28.78 26.84

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 3.28 -6.59 12.82 9.30 6.87 4.77 5.85 7.88 -0.78 4.48 PBT 3.45 3.87 10.51 5.64 6.07 4.73 2.92 0.88 0.80 0.58 Adjustment 2.13 1.60 1.33 1.64 1.72 2.02 1.88 2.16 2.22 2.00 Changes in Working Capital -2.30 -12.07 0.98 2.02 -0.92 -0.69 1.68 4.84 -3.81 1.90 Cash after chg. in Working capital 3.28 -6.59 12.82 9.30 6.87 6.05 6.49 7.88 -0.78 4.48 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 -1.28 -0.64 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -5.08 -5.34 -3.51 -2.21 -3.19 -1.75 -1.56 -2.44 -0.73 -0.56 Net Fixed Assets -4.08 -4.61 -0.37 -0.67 -1.62 -1.80 -1.16 -2.52 -0.78 -0.62 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -1.00 -0.73 -3.14 -1.54 -1.57 0.05 -0.40 0.08 0.05 0.06 Cash from Financing Activity -8.18 9.79 -0.46 -5.52 -1.83 -1.77 -3.81 -5.34 0.53 -2.99 Net Cash Inflow / Outflow -9.98 -2.14 8.85 1.58 1.86 1.24 0.47 0.09 -0.98 0.93 Opening Cash & Equivalents 12.40 14.54 5.68 4.11 2.25 1.01 0.53 0.44 1.42 0.49 Closing Cash & Equivalent 2.42 12.40 14.54 5.68 4.11 2.25 1.01 0.53 0.44 1.42

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 54.87 50.58 45.86 34.49 27.94 20.82 15.10 13.78 12.36 11.07 ROA 4.40% 5.87% 19.34% 12.32% 13.78% 12.34% 3.11% 3.24% 2.89% 2.04% ROE 7.43% 9.47% 28.67% 20.84% 28.95% 31.53% 9.06% 10.83% 11.01% 8.76% ROCE 9.92% 12.20% 38.88% 24.80% 29.12% 28.65% 20.24% 11.21% 10.76% 9.40% Fixed Asset Turnover 2.08 2.05 2.25 1.85 2.13 2.02 2.10 1.90 2.21 2.38 Receivable days 89.77 75.03 44.00 59.53 65.79 71.86 62.81 83.84 68.35 62.69 Inventory Days 55.24 24.40 22.23 30.99 18.96 12.60 27.79 61.30 71.45 74.39 Payable days 83.56 59.08 67.05 51.48 47.58 55.90 51.82 53.73 47.08 62.09 Cash Conversion Cycle 61.45 40.35 -0.82 39.04 37.17 28.56 38.78 91.41 92.71 74.99 Total Debt/Equity 0.19 0.44 0.11 0.15 0.46 0.71 1.05 1.47 2.13 2.14 Interest Cover 5.23 5.69 23.92 10.76 7.95 4.90 3.49 1.53 1.48 1.38

Top Investors:

kirtilaben jayantilal mehta

padrone marketing private limited

Annual Reports:

News Update:

Auro Laboratories - Quarterly Results
6th Feb 2024, 17:41 PM

Read More
Auro Laboratories inks pact with MIDC
25th Jan 2024, 10:30 AM

The agreement is for acquisition of leasehold land for future expansion purpose
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback